NVIGEN
Sunnyvale, US · Founded 2011 · 12 employees on LinkedIn · 1 known investors
Find your way into NVIGEN
NVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
Founders & leadership
NVIGEN was founded in 2011 by Aihua Fu.
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2014
▶$1.1MraisedMar 2014 · 13 investors · BiotechnologyRule 506(b)
- Xiangdong JinExecutive Officer
- Guoliang YuDirector
- Aihua FuExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Mar 2014
- Incorporated
- Corporation, California, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $275.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $201.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does NVIGEN do?
- NVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
- Who founded NVIGEN?
- NVIGEN was founded by Aihua Fu in 2011.
- Who are NVIGEN's investors?
- NVIGEN's investors include Foothill Ventures.
- How much funding has NVIGEN raised?
- NVIGEN has disclosed $1.1M raised across 1 round.
- Where is NVIGEN headquartered?
- NVIGEN is headquartered in Sunnyvale, US.